NB Luna Ramirez , MS Orlando , NB Barba , E Shippey , E Flores , P Garcia-Filion , R Kho
{"title":"Incidence of Abdominal Wall Endometriosis After Cesarean Delivery","authors":"NB Luna Ramirez , MS Orlando , NB Barba , E Shippey , E Flores , P Garcia-Filion , R Kho","doi":"10.1016/j.jmig.2024.09.068","DOIUrl":null,"url":null,"abstract":"<div><h3>Study Objective</h3><div>Abdominal wall endometriosis (AWE), a sequelae of cesarean delivery (CD), has been reported to occur in 0.03%-0.45% in small cohort reports. The true incidence is currently unknown. This study aims to identify the true incidence of AWE and risk factors for its development.</div></div><div><h3>Design</h3><div>A prospective study to measure the incidence of AWE in patients that underwent primary CD between 2010 and 2023. Cases of primary CD were identified using the national Vizient Clinical Database and followed in time for diagnosis of AWE.</div></div><div><h3>Setting</h3><div>National database that collects de-identified information from over 500 academic and community hospitals in the US.</div></div><div><h3>Patients or Participants</h3><div>Cohort of patients that underwent primary CD from 2010-2023 derived from a population-based database. Identified using ICD-codes.</div></div><div><h3>Interventions</h3><div>None.</div></div><div><h3>Measurements and Main Results</h3><div>The study cohort has 2,356,503 cases of CD. Median age is [31.0 years (interquartile range: 27, 35)]. AWE was diagnosed in 18,030 (0.8%) of patients and 93% (n=16812) occurred after primary CD. The median time to diagnosis is 2.9 years (1.46, 4.91). The population incidence rate was 1.70/1000 person-years (1.67, 1.72) in women after primary CD. Incidence rates rose with increasing maternal age at primary CD: 18-24 years [0.90/1000 person-years (0.86, 0.95)], 25-29 years [1.48/1000 person-years (1.43, 1.53)], 30-34 years [1.79/1000 person-years (1.75, 1.84)], 35-39 years [2.21/1000 person-years (2.15, 2.27)], and 40 years and older [2.42/1000 years (2.31,2.54)]. Increasing risk with maternal age was statistically significant for a positive linear trend (p<sub>trend</sub><0.001). Risk factor for AWE include private insurance [1.59 (1.54, 1.65)], white [1.73 (1.6, 1.79)], smoking status at CD [2.06 (1.98, 2.15)], and BMI 25-29 kg/m2[2.01 (1.92, 2.10)].</div></div><div><h3>Conclusion</h3><div>This is the first study to calculate the true incidence of AWE. This study provides greater understanding of the condition and its risk factors.</div></div>","PeriodicalId":16397,"journal":{"name":"Journal of minimally invasive gynecology","volume":"31 11","pages":"Page S1"},"PeriodicalIF":3.5000,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of minimally invasive gynecology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S155346502400476X","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Study Objective
Abdominal wall endometriosis (AWE), a sequelae of cesarean delivery (CD), has been reported to occur in 0.03%-0.45% in small cohort reports. The true incidence is currently unknown. This study aims to identify the true incidence of AWE and risk factors for its development.
Design
A prospective study to measure the incidence of AWE in patients that underwent primary CD between 2010 and 2023. Cases of primary CD were identified using the national Vizient Clinical Database and followed in time for diagnosis of AWE.
Setting
National database that collects de-identified information from over 500 academic and community hospitals in the US.
Patients or Participants
Cohort of patients that underwent primary CD from 2010-2023 derived from a population-based database. Identified using ICD-codes.
Interventions
None.
Measurements and Main Results
The study cohort has 2,356,503 cases of CD. Median age is [31.0 years (interquartile range: 27, 35)]. AWE was diagnosed in 18,030 (0.8%) of patients and 93% (n=16812) occurred after primary CD. The median time to diagnosis is 2.9 years (1.46, 4.91). The population incidence rate was 1.70/1000 person-years (1.67, 1.72) in women after primary CD. Incidence rates rose with increasing maternal age at primary CD: 18-24 years [0.90/1000 person-years (0.86, 0.95)], 25-29 years [1.48/1000 person-years (1.43, 1.53)], 30-34 years [1.79/1000 person-years (1.75, 1.84)], 35-39 years [2.21/1000 person-years (2.15, 2.27)], and 40 years and older [2.42/1000 years (2.31,2.54)]. Increasing risk with maternal age was statistically significant for a positive linear trend (ptrend<0.001). Risk factor for AWE include private insurance [1.59 (1.54, 1.65)], white [1.73 (1.6, 1.79)], smoking status at CD [2.06 (1.98, 2.15)], and BMI 25-29 kg/m2[2.01 (1.92, 2.10)].
Conclusion
This is the first study to calculate the true incidence of AWE. This study provides greater understanding of the condition and its risk factors.
期刊介绍:
The Journal of Minimally Invasive Gynecology, formerly titled The Journal of the American Association of Gynecologic Laparoscopists, is an international clinical forum for the exchange and dissemination of ideas, findings and techniques relevant to gynecologic endoscopy and other minimally invasive procedures. The Journal, which presents research, clinical opinions and case reports from the brightest minds in gynecologic surgery, is an authoritative source informing practicing physicians of the latest, cutting-edge developments occurring in this emerging field.